Loss of Regulatory Immune Function in Coronary Artery Disease Patients from the Indian Population

Thiruvelselvan Ponnusamy1, Srikanth Komarulu Venkatachala2, Manjunatha Ramanujappa3

  • 1Research Scholar at Manipal University, Molecular Immunology Unit, Thrombosis Research Institute, Bangalore, India.

Insights

Inflammatory T cells and monocytes increase with coronary artery disease severity. These cells, particularly Th17 cells, show heightened responses and impaired regulation, contributing to disease progression and recurrent cardiac events.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Pathophysiology

Background:

  • The role of specific inflammatory immune cells in coronary artery disease (CAD) manifestations remains unclear.
  • Understanding immune cell subsets in different CAD presentations is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the frequency and function of inflammatory T cell and monocyte subsets in various CAD manifestations.
  • To correlate immune cell profiles with clinical outcomes, including recurrent cardiac events and clinical improvement.

Main Methods:

  • Flow cytometry analysis of T cell (Th17, Treg) and monocyte subsets in 181 CAD patients (stable angina, NSTEMI, STEMI, unstable angina) and 34 controls.
  • Assessment of cellular responses to autoantigens (HSP60), regulatory cell function, foam cell formation, and macrophage differentiation.
  • Longitudinal sample collection during cardiac events and clinical improvement.

Main Results:

  • A stepwise increase in Th17 cells and monocytes was observed across the spectrum from stable angina to unstable angina.
  • Higher proportions of inflammatory cells correlated positively with recurrent cardiac events and inversely with clinical improvement.
  • CAD patients exhibited Th17 cell expansion in response to autoantigen HSP60 and impaired regulatory T cell (Treg) function.

Conclusions:

  • Stress-induced activation of inflammatory cells, specifically Th17 cells and monocytes, is implicated in CAD progression.
  • Compromised Treg function exacerbates the inflammatory response in CAD patients.
  • Immune cell profiling offers potential biomarkers for CAD severity and prognosis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K